Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,354,400 | 1,369,400 | 1,329,900 | 1,011,500 | 1,243,400 |
| Cost of Goods | 262,900 | 275,500 | 286,900 | 141,400 | 250,600 |
| Gross Profit | 1,091,500 | 1,093,900 | 1,043,000 | 870,100 | 992,800 |
| Operating Expenses | 741,800 | 727,900 | 694,900 | 579,400 | 627,500 |
| Operating Income | 350,600 | 366,500 | 349,000 | 291,100 | 365,900 |
| Other Income | 52,200 | 17,500 | 22,200 | 20,000 | 21,700 |
| Pre-tax Income | 402,800 | 384,000 | 371,200 | 311,100 | 387,600 |
| Income Tax | 40,700 | 20,000 | 46,300 | 20,700 | 52,700 |
| Net Income Continuous | 362,100 | 364,000 | 324,900 | 290,400 | 334,900 |
| Net Income Discontinuous | 2,707,300 | 1,000 | 26,100 | 79,300 | 48,800 |
| Minority Interests | -1,400 | -1,300 | -900 | -200 | -1,200 |
| Net Income | $3,070,800 | $366,300 | $351,900 | $369,900 | $384,900 |
| EPS Basic Total Ops | 5.14 | 0.61 | 0.58 | 0.61 | 0.63 |
| EPS Basic Continuous Ops | 0.61 | 0.61 | 0.54 | 0.49 | 0.55 |
| EPS Basic Discontinuous Ops | 4.53 | 0.00 | 0.04 | 0.12 | 0.08 |
| EPS Diluted Total Ops | 5.13 | 0.61 | 0.58 | 0.61 | 0.63 |
| EPS Diluted Continuous Ops | 0.61 | 0.61 | 0.54 | 0.48 | 0.55 |
| EPS Diluted Discontinuous Ops | 4.52 | 0.00 | 0.04 | 0.13 | 0.08 |
| EPS Diluted Before Non-Recurring Items | 0.67 | 0.70 | 0.66 | 0.64 | N/A |
| EBITDA(a) | $385,100 | $406,100 | $387,500 | $327,800 | $402,800 |